WEBULL
WebtradeDownload

Profit Loss Could Be A Game Changer For Mosaic Stock (MOS)

Simply Wall St · 1d ago
  • Mosaic recently reported pressured profitability, with a challenging profit margin and earnings per share in loss territory, underlining ongoing earnings headwinds across its fertilizer operations.
  • The latest results highlight how cost pressures and weaker earnings can complicate Mosaic's effort to reshape its portfolio toward higher margin products such as Mosaic Biosciences.
  • Investors will now be watching how Mosaic's weaker profit margin and loss-making earnings profile might reshape its investment narrative over the long term.

Balance the pressure in Mosaic's fertilizer earnings by scanning a hand-picked 29 high quality undervalued stocks that share stronger profitability profiles and more resilient cash generation.

Mosaic Investment Narrative Recap

To own Mosaic, you need to believe the fertilizer cycle and the company’s portfolio reshaping can eventually support consistent profitability again. The recent loss making earnings profile puts that belief under pressure in the near term. The key short term swing factor is how quickly cost inputs and product mix shift toward higher margin lines such as Mosaic Biosciences.

The biggest current risk is that weak operating cash flow, alongside heavy capital expenditure and dividends, keeps the business cash flow negative and restricts future investment options. The latest profitability hit reinforces that concern. If sulfur costs, production curtailments or regulatory pressure persist, the path to steadier margins could stay bumpy.

Recent guidance around capital allocation and cost discipline is most relevant here because it connects directly to Mosaic’s loss making earnings and pressured margin. Management has highlighted plans for lower capital expenditure of about US$1.2b in 2026 and an expected US$300 million to US$500 million working capital release. That matters for a company with roughly US$270 million of year to date operating cash flow against about US$1.5b of combined capex and dividends.

The same update outlined further SG&A reductions after a 20% year over year cut in Q2, plus sulfur contracts that support healthier implied DAP stripping margins if market conditions hold. For investors, the question is whether those operational levers offset idle costs from curtailed phosphate production and any pressure on pricing power from political scrutiny and new domestic fertilizer capacity over the next few years.

Mosaic's current analyst storyline points to US$13.2b in revenue and US$674.0m in earnings by 2029, based on a 2.5% yearly revenue growth rate and an earnings swing of about US$1.3b from today’s loss of US$638.5m to the forecast profit.

Uncover why Mosaic's fair value signals a 34% potential upside to its current price, which could narrow quickly if sentiment on Mosaic shifts.

NYSE:MOS 1-Year Stock Price Chart
NYSE:MOS 1-Year Stock Price Chart

Exploring Other Perspectives

For Mosaic, the bearish twist centers on sulfur. The most pessimistic analysts worry that prolonged sulfur constraints keep phosphate curtailed and idle costs high, so their 2029 view sits closer to US$11.4b in revenue and US$412.1m in earnings. That is far below consensus, and this latest profit setback could push opinions even further apart.

Explore 5 other Mosaic fair value estimates, including one that suggests as much as 10% downside from the current price.

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Looking For More Ideas Beyond Mosaic?

Once you have a view on Mosaic, it can help to widen the lens and compare it with other opportunities that match your risk tolerance, income needs, or balance sheet preferences. The Simply Wall St Screener lets you do exactly that by filtering for specific traits that matter most to you.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.